Loading
A phase 1/2 trial of pTTL in colorectal cancer, run by Neogap Therapeutics AB, now recruiting.
A First-In-Human Trial of pTTL in Advanced Colorectal Cancer is a phase 1/2 interventional study registered as NCT05908643 by Neogap Therapeutics AB, with 16 participants planned, started 2023-03-15 and due to reach its primary completion in 2027-12. Interventions recorded: pTTL.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.
Shares Colorectal cancer and the tag pipeline.